The effect of calcium, Vitamin D, and denosumab on osteoporosis and basal metabolism in postmenopausal diabetic wome
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes Mellitus, Osteoporosis
- Registration Number
- JPRN-UMIN000023292
- Lead Sponsor
- Tokyo Women's Mediclcal University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who Taking drug for osteoporosis With presence and past history of malignancy. With other endocrine diseases With liver dysfunction except fatty liver With macro proteinuria or with increased serum creatinine level over 2.0mg/dl Principal investigator of this study has determined to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of the Basal metabolism, and the marker of the bone metabolism before and after taking Calcium/Vitamin D and denosumab
- Secondary Outcome Measures
Name Time Method Changes of the blood glucose control level, fasting CPR, iPTH, 25hydroxyvitamin D, blood cell count, serum calcium, phosphate and other general examination of blood, and diabetic neuropathy